Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Receivables: 2017-2020

Historic Change in Receivables for Cogent Biosciences (COGT) over the last 4 years, with Dec 2020 value amounting to -$2.0 million.

  • Cogent Biosciences' Change in Receivables fell 637.63% to -$2.0 million in Q1 2020 from the same period last year, while for Mar 2020 it was -$2.0 million, marking a year-over-year decrease of 564.69%. This contributed to the annual value of -$2.0 million for FY2020, which is 702.41% down from last year.
  • Latest data reveals that Cogent Biosciences reported Change in Receivables of -$2.0 million as of FY2020, which was down 702.41% from $332,000 recorded in FY2019.
  • In the past 5 years, Cogent Biosciences' Change in Receivables ranged from a high of $838,000 in FY2018 and a low of -$2.0 million during FY2020.
  • Moreover, its 3-year median value for Change in Receivables was $332,000 (2019), whereas its average is -$276,667.
  • Per our database at Business Quant, Cogent Biosciences' Change in Receivables soared by 955.10% in 2018 and then crashed by 702.41% in 2020.
  • Over the past 4 years, Cogent Biosciences' Change in Receivables (Yearly) stood at -$98,000 in 2017, then surged by 955.10% to $838,000 in 2018, then plummeted by 60.38% to $332,000 in 2019, then plummeted by 702.41% to -$2.0 million in 2020.